[Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
We studied a significance of serum CA72-4 as a follow up of recurrent gastric cancer in 24 recurrent cases with gastric cancer performed combination assay of CEA, CA19-9 and CA72-4. Positive rate of CA72-4 was 58.3%, which was almost same as that of CEA. Lymph node metastasis and peritoneal dissemination were observed relatively high rate in positive cases with serum CA72-4. Comparison of an elevation time of CEA and CA72-4 in recurrent cases showed that CEA earlier than CA72-4 was 3 cases, CA72-4 earlier than CEA was 3 cases, and the others were about same. These results indicated that CA72-4 was a useful tumor marker as a follow up of recurrent gastric cancer.